Global Health

  1. Naqvi A, GBD 2021 Europe Life Expectancy Collaborators. Changing life expectancy in European countries 1990-2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021. The Lancet Public Health. 2025;10(3):e172-e188.
  2. Lee S, Son Y, Hwang J, Kim MS, Il Shin J, Yon DK, Kassebaum NJ. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study. Nature Medicine. 2025;:1-21.
  3. Alkahlout L, Hamran S, Darwish N, Dweidri Y, Babu GR, Al Saady RM. The Association Between Estrogen‐Containing Oral Contraceptive Pills and Hypothyroidism. International Journal of Endocrinology. 2025;2025(1):5978558.
  4. Bennitt FB, Wozniak S, Causey K, Spearman S, Okereke C, Garcia V, Hashmeh N, Ashbaugh C, Abdelkader A, Abdoun M. Global, regional, and national burden of household air pollution, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2025;405(10485):1167-1181.
  5. Steel N, Bauer-Staeb CMM, Ford JA, Abbafati C, Abdalla MA, Abdelkader A, Abdi P, Zuñiga RAA, Abiodun OO, Abolhassani H. Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021. The Lancet Public Health. 2025;10(3):e172-e188.
  6. Kyu HH, Vongpradith A, Dominguez RV, Ma J, Albertson SB, Novotney A, Khalil IA, Troeger CE, Doxey MC, Ledesma JR. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Infectious Diseases. 2025;25(5):519-536.
  7. GBD 2021 China Neurological Disorders Collaborators. Burden of neurological disorders in China and its provinces, 1990–2021: Findings from the global burden of disease study 2021. Med. 2025;:.
  8. Zhang C, Yang X, Wan D, Ma Q, Yin P, Zhou M, Hao J. Burden of neurological disorders in China and its provinces, 1990–2021: Findings from the global burden of disease study 2021. Med. 2025;:.
  9. Nicholas S, Bauer-Staeb CMM, Ford JA, Abbafati C, Abdalla MA, Abdelkader A, Abdi P, Abeldaño Zuñiga RA, Abiodun OO, Abolhassani H. Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021. . 2025;:.
  10. Rautalin I, Volovici V, Stark BA, Johnson CO, Kaprio J, Korja M, Krishnamurthi RV, Nair BS, Ranta A, Rinkel GJ. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021. JAMA neurology. 2025;:.
  11. Ferrari AJ, Santomauro DF, Aali A, Abate YH, Abbafati C, Abbastabar H, Abd ElHafeez S, Abdelmasseh M, Abd-Elsalam S, Abdollahi A. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2024;403(10440):2133-2161.
  12. Vollset SE, Ababneh HS, Abate YH, Abbafati C, Abbasgholizadeh R, Abbasian M, Abbastabar H, Abd Al Magied AH, Abd ElHafeez S, Abdelkader A. Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021. The Lancet. 2024;403(10440):2204-2256.
  13. Brauer M, Roth GA, Aravkin AY, Zheng P, Abate KH, Abate YH, Abbafati C, Abbasgholizadeh R, Abbasi MA, Abbasian M. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2024;403(10440):2162-2203.
  14. Naghavi M, Ong KL, Aali A, Ababneh HS, Abate YH, Abbafati C, Abbasgholizadeh R, Abbasian M, Abbasi-Kangevari M, Abbastabar H. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2024;403(10440):2100-2132.
  15. Bhattacharjee NV, Schumacher AE, Aali A, Abate YH, Abbasgholizadeh R, Abbasian M, Abbasi-Kangevari M, Abbastabar H, Abd ElHafeez S, Abd-Elsalam S. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. The lancet. 2024;403(10440):2057-2099
  16. Zar A, Abdulrahman S, Abdulrahman A, Framarzi M, Almalki A, Karen A, Elkhalaf A, Babu G. Does prenatal tobacco exposure affect child neurodevelopment? An ECHO cohort study. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. 2024;131:95-95.
  17. Mokdad AH, Bisignano C, Hsu JM, Bryazka D, Cao S, Bhattacharjee NV, Dalton BE, Lindstedt PA, Smith AE, Ababneh HS. Burden of disease scenarios by state in the USA, 2022–50: a forecasting analysis for the Global Burden of Disease Study 2021. The Lancet. 2024;404(10469):2341-2370.
  18. Carter A, Zhang M, Tram KH, Walters MK, Jahagirdar D, Brewer ED, Novotney A, Lasher D, Mpolya EA, Vongpradith A. Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021. The Lancet HIV. 2024;11(12):e807-e822.
  19. Bryazka D, Reitsma MB, Abate YH, Abd Al Magied AH, Abdelkader A, Abdollahi A, Abdoun M, Abdulkader RS, Zuniga RAA, Abhilash E. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The lancet Public health. 2024;9(10):e729-e744.
  20. Feigin VL, Abate MD, Abate YH, Abd ElHafeez S, Abd-Allah F, Abdelalim A, Abdelkader A, Abdelmasseh M, Abd-Elsalam S, Abdi P. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Neurology. 2024;23(10):973-1003.
  21. Erchick DJ, Hazel E, Katz J, Lee A, Diaz M, Wu L, Yoshida S, Bahl R, Grandi C, Labrique A. Vulnerable newborn types: analysis of subnational, population‐based birth cohorts for 541 285 live births in 23 countries, 2000–2021. BJOG: An International Journal of Obstetrics & Gynaecology. 2023;:.
  22. Elsayed BM, Altarawneh L, Farooqui HH, Khan MN, Babu GR, Doi SA, Chivese T. Association between pre-existing conditions and hospitalization, intensive care services and mortality from COVID-19–a cross sectional analysis of an international global health data repository. medRxiv. 2023;:2023.08. 31.23294901
  23. Sahu B, Tamysetty S, Babu GR, Saldanha ND, Bhatia R, Khetrapal S. Suicide during the pandemic in an informal settlement of Bengaluru. International journal of health sciences and research. 2023;13(1):170-183
  24. Hebbar PB, Dsouza V, Bhojani U, Prashanth NS, Van Schayck OC, Babu GR, Nagelhout GE. How do tobacco control policies work in low-income and middle-income countries? A realist synthesis. BMJ Global Health. 2022;7(11):e008859.
  25. Sethi V, Choedon T, Chowdhury R, Bhatia N, Dinachandra K, Murira Z, Bhanot A, Baswal D, de Wagt A, Bhargava M. Screening and management options for severe thinness during pregnancy in India. International Journal of Gynecology & Obstetrics. 2021;155(3):357-379.
  26. Babu GR, Khetrapal S, John DA, Deepa R, Narayan KV. Pandemic preparedness and response to COVID-19 in South Asian countries. International Journal of Infectious Diseases. 2021;104:169-174.
  27. Murhekar MV, Bhatnagar T, Selvaraju S, Saravanakumar V, Thangaraj JWV, Shah N, Kumar MS, Rade K, Sabarinathan R, Asthana S. SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey. The Lancet Global Health. 2021;9(3):e257-e266.
  28. Babu GR, Ray D, Bhaduri R, Halder A, Kundu R, Menon GI, Mukherjee B. COVID-19 pandemic in India: through the lens of modeling. Global Health: Science and Practice. 2021;9(2):220-228.
  29. Murhekar MV, Bhatnagar T, Thangaraj JWV, Saravanakumar V, Kumar MS, Selvaraju S, Rade K, Kumar CG, Sabarinathan R, Turuk A. SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021. International Journal of Infectious Diseases. 2021;108:145-155.
  30. Babu GR, Sundaresan R, Athreya S, Akhtar J, Pandey PK, Maroor PS, Padma MR, Lalitha R, Shariff M, Krishnappa L. The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide sentinel-based population survey in Karnataka, India. International Journal of Infectious Diseases. 2021;108:27-36.
  31. Choedon T, Sethi V, Chowdhury R, Bhatia N, Dinachandra K, Murira Z, Bhanot A, Baswal D, de Wagt A, Bhargava M. Population estimates and determinants of severe maternal thinness in India. International Journal of Gynecology & Obstetrics. 2021;155(3):380-397.
  32. Boudewijns EA, Babu GR, Salvi S, Sheikh A, van Schayck OC. Chronic obstructive pulmonary disease: a disease of old age?. Journal of Global Health. 2018;8(2):1-3.
  33. Chen G, Cao Y, Yao Y, Li M, Tang W, Li J, Babu GR, Jia Y, Huan X, Xu G. Syphilis incidence among men who have sex with men in China: results from a meta-analysis. International journal of STD & AIDS. 2017;28(2):170-178.
  34. Tang WeiMing TW, Babu G, Li JianJun LJ, Zhang Ye ZY, Fu GengFeng FG, Huan XiPing HX, Tucker J, Zhao JinKou ZJ, Detels R. The difference between HIV and syphilis prevalence and incidence cases: results from a cohort study in Nanjing, China, 2008-2010. . 2015;:.
  35. Fu G, Jiang N, Hu H, Mahapatra T, Yin Y, Mahapatra S, Wang X, Chen X, Babu GR, Xu X. The epidemic of HIV, syphilis, chlamydia and gonorrhea and the correlates of sexual transmitted infections among men who have sex with men in Jiangsu, China, 2009. PloS one. 2015;10(3):e0118863.
  36. Tang W, Babu GR, Li J, Zhang Y, Fu G, Huan X, Tucker JD, Zhao J, Detels R. The difference between HIV and syphilis prevalence and incidence cases: results from a cohort study in Nanjing, China, 2008–2010. International journal of STD & AIDS. 2015;26(9):648-655.
  37. Huan X, Tang W, Babu GR, Li J, Zhang M, Liu X, Yan H, Fu G, Zhao J, Yang H. HIV risk-reduction counseling and testing on behavior change of MSM. PloS one. 2013;8(7):e69740.
  38. Das A, Babu GR, Ghosh P, Mahapatra T, Malmgren R, Detels R. Epidemiologic correlates of willingness to be tested for HIV and prior testing among married men in India. International journal of STD & AIDS. 2013;24(12):957-968.
  39. Huan XiPing HX, Tang W, Babu G, Li JianJun LJ, Zhang Min ZM, Liu XiaoYan LX, Yan HongJing YH, Fu GengFeng FG, Zhao JinKou ZJ, Yang HaiTao YH. HIV risk-reduction counseling and testing on behavior change of MSM. . 2013;:.
  40. Aritra Das AD, Babu G, Puspen Ghosh PG, Tanmay Mahapatra TM, Malmgren R, Detels R. Epidemiologic correlates of willingness to be tested for HIV and prior testing among married men in India. . 2013;:.
  41. Ghosh P, Arah O, Talukdar A, Sur D, Babu G, Sengupta P, Detels R. Factors associated with HIV infection among Indian women. International journal of STD & AIDS. 2011;22(3):140-145.
  42. Babu GR, Olsen J, Jana S, Nandy S, Farid MN, Sadhana S, Kadam S. Evaluation of Immunization Services in high-risk district in India. International J. of Medicine and Public Health. 2011;1(3):17-21

Global Health in Action: Hear from Dr. Giridhara R Babu on Transforming Population Health